These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 13694099

  • 1. Nitrogen-mustard therapy combined with autologous marrow infusion.
    CLIFFORD P, CLIFT RA, DUFF JK.
    Lancet; 1961 Apr 01; 1(7179):687-90. PubMed ID: 13694099
    [No Abstract] [Full Text] [Related]

  • 2. Contributions to the treatment of cancer of the head and neck. Nitrogen mustard toxicity and bone marrow infusion.
    CLIFT RA.
    East Afr Med J; 1961 Nov 01; 38():500-2. PubMed ID: 13879952
    [No Abstract] [Full Text] [Related]

  • 3. Disseminated abdominal melanoma treated by massive dosage of nitrogen mustard and autogenous bone-marrow replacement.
    JONES KO, REEVE TS, PIPER DW, CUMBERLAND VH.
    Med J Aust; 1960 Jul 09; 47(2)():61-3. PubMed ID: 14407740
    [No Abstract] [Full Text] [Related]

  • 4. Treatment of disseminated melanoma with phenylalanine mustard (melphelan) and autogenous bone marrow transplants.
    ARIEL IM, PACK GT.
    Surgery; 1962 May 09; 51():583-91. PubMed ID: 13862259
    [No Abstract] [Full Text] [Related]

  • 5. Protective action of autologous marrow against nitrogen mustard toxicity.
    BLACK MM, SPEER FD, STONE ML.
    Ann Intern Med; 1959 Sep 09; 51():517-25. PubMed ID: 13801160
    [No Abstract] [Full Text] [Related]

  • 6. Massive nitrogen mustard therapy in Hodgkin's disease with protection of bone marrow by tourniquets.
    CONRAD ME, CROSBY WH.
    Blood; 1960 Aug 09; 16():1089-103. PubMed ID: 13811574
    [No Abstract] [Full Text] [Related]

  • 7. [A contribution to the chemotherapy of cancer with N-oxide-mustard].
    HAMMER O, TAUTENHAHN B.
    Med Nov; 1959 Aug 29; 35():1562-6. PubMed ID: 14399321
    [No Abstract] [Full Text] [Related]

  • 8. Prolonged intravenous infusion chemotherapy of advanced cancer. I. Combined therapy with introgen mustard plus actinomycin D, thioTEPA plus actinomycin D, and thioTEPA plus actinomycin P2.
    LEONE LA, COLBERT MP, YORK CL.
    Cancer Chemother Rep; 1961 Dec 29; 15():21-32. PubMed ID: 14464104
    [No Abstract] [Full Text] [Related]

  • 9. Palliation achieved in carcinoma of the head and neck with intra-arterial chemotherapy.
    KLOPP CT, SMITH DF, ALFORD TC.
    Am J Surg; 1961 Dec 29; 102():830-4. PubMed ID: 14457097
    [No Abstract] [Full Text] [Related]

  • 10. The effect of nitrogen mustard on granulocytic cells as observed by the marrow culture technic.
    OSGOOD EE, CHU IT.
    Cancer Res; 1950 Feb 29; 10(2):98-102. PubMed ID: 15403006
    [No Abstract] [Full Text] [Related]

  • 11. [Bone-marrow transplantation in patients with bone-marrow depression. Aplastic anemia after nitrogen mustard therapy].
    HEYL T.
    S Afr Med J; 1961 Jul 22; 35():604-7. PubMed ID: 13714064
    [No Abstract] [Full Text] [Related]

  • 12. Bone marrow protection as a potential aid to chemotherapy.
    AMBRUS CM, BACK N, AMBRUS JL.
    Acta Unio Int Contra Cancrum; 1960 Jul 22; 16():540-1. PubMed ID: 13793133
    [No Abstract] [Full Text] [Related]

  • 13. The alkaline phosphatase content of human leukocytes following marrow suppression by nitrogen mustard.
    TRUBOWITZ S, FELDMAN D, BENANTE C, HUNT VM.
    J Lab Clin Med; 1958 Aug 22; 52(2):259-65. PubMed ID: 13564003
    [No Abstract] [Full Text] [Related]

  • 14. Bone marrow protection in mechlorethamine (nitrogen mustard) therapy.
    MILLER DG, LAWRENCE W.
    Arch Surg; 1962 Sep 22; 85():430-41. PubMed ID: 14473972
    [No Abstract] [Full Text] [Related]

  • 15. Disseminated malignant melanoma: response to treatment by massive dosage of a cytotoxic agent combined with autogenous marrow replacement.
    WESTBURY G, HUMBLE JG, NEWTON KA, SKINNER ME, PEGG DE.
    Lancet; 1959 May 09; 1(7080):968-9. PubMed ID: 13655649
    [No Abstract] [Full Text] [Related]

  • 16. HEMODYNAMIC EFFECTS OF OCCLUSION OF THE ABDOMINAL AORTA DURING NITROGEN-MUSTARD THERAPY.
    HARRIES JR.
    Am Heart J; 1964 Nov 09; 68():713-4. PubMed ID: 14222412
    [No Abstract] [Full Text] [Related]

  • 17. The effect of enzymatic agents, nitrogen mustard and phenergan on autologous and homologous split thickness grafts in humans.
    ABSOLON KB, LENHARDT HF.
    Plast Reconstr Surg Transplant Bull; 1960 Apr 09; 25():411-3. PubMed ID: 13791597
    [No Abstract] [Full Text] [Related]

  • 18. [Clinical application to cancer chemotherapy of nitrogen-mustard N-oxide].
    KATSUNUMA S.
    Gan; 1952 Sep 09; 43(2-3):174-5. PubMed ID: 12998802
    [No Abstract] [Full Text] [Related]

  • 19. [Marrow protection with pentnucleotides during treatment with cytotoxic drugs].
    ANDREU URRA J, RIVERO FONTAN JL.
    Hisp Med; 1955 Sep 09; 12(135):435-8. PubMed ID: 13306135
    [No Abstract] [Full Text] [Related]

  • 20. The effect of intra-arterial nitrogen-mustard therapy on human skin.
    SULLIVAN RD, MESCON H, JONES R.
    Cancer; 1953 Mar 09; 6(2):288-93. PubMed ID: 13032919
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.